The application of SPECT/CT for preoperative planning in patients with secondary hyperparathyroidism

Nuclear Medicine Communications

Volumn 34, Issue 5, 2013, Pages 439-444

  Zhen, Lishi ^a   Li, Huan ^a   Liu, Xiaojian ^a   Ge, Benjamin H ^c   Yan, Jue ^a   Yang, Jigang ^b  

^a CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

99mTc sestamibi; delayed static planar image; early static planar image; secondary hyperparathyroidism; SPECT CT

Indexed keywords

CALCIUM; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PARATHYROID HORMONE;

AGED; ARTICLE; CALCIUM BLOOD LEVEL; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PARATHYROID GLAND; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID SCINTISCANNING; PARATHYROIDECTOMY; PREOPERATIVE PERIOD; SECONDARY HYPERPARATHYROIDISM; SENSITIVITY AND SENSIBILITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT PLANNING;

AGED; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PREOPERATIVE PERIOD; TECHNETIUM TC 99M SESTAMIBI;

EID: 84876407398     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32835f9447     Document Type: Article

References (23)

1. Slatopolsky E, Brown A, Dusso A. Pathogenesis of secondary hyperparathyroidism. Kidney Int Suppl 1999; 73:S14-S19.
2. Cunningham J, Locatelli F, Rodriguez M. Secondary hyperparathyroidism: Pathogenesis, disease progression, and therapeutic options. Clin J Am Soc Nephrol 2011; 6:913-921.
3. Mulpio C, Bossola M, De Gaetano A, Maresca G, Bruno I, Fadda G, et a.l. Usefulness of the combination of ultrasonography and 99mTc-sestamibi scintigraphy in the preoperati Me e Maluation of uremic secondary hyperparathyroidism. Head Neck 2010; 32:1226-1235.
4. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42:S1-S201.
5. Giordano A, Rubello D, Casara D. New trends in parathyroid scintigraphy. Eur J Nucl Med 2001; 28:1409-1420.
6. Fukuda N, Tanaka H, Tominaga Y, Fukagawa M, Kurokawa K, Seino Y. Decreased 1,25-dihydroxy Mitamin D3 receptor density is associated with a more se Mere form of parathyroid hyperplasia in chronic uremic patients. J Clin In Mest 1993; 92:1436-1443.
7. Chen L, Luo Q, Shen Y, Yu Y, Yuan Z, Lu H, et a.l. Incremental Malue of 131I SPECT/CT in the management of patients with differentiated thyroid carcinoma. J Nucl Med 2008; 49:1952-1957.
8. Wang H, Fu HL, Li JN, Zou RJ, Gu ZH, Wu J.C. The role of single-photon emission computed tomography/computed tomography for precise localization of metastases in patients with differentiated thyroid cancer. Clin Imaging 2009; 33:49-54.
9. E Men-Sapir E. Imaging of malignant bone in Mol Mement by morphologic, scintigraphic, and hybrid modalities. J Nucl Med 2005; 46: 1356-1367.
10. Tominaga Y, Matsuoka S, Uno N, Sato T. Parathyroidectomy for secondary hyperparathyroidism in the era of calcimimetics. Ther Apher Dial 2008; 12 (Suppl 1):S21-S26.
11. Ciappuccini R, Morera J, Pascal P, Rame JP, Heutte N, Aide N, et a.l. Dual-phase 99mTc sestamibi scintigraphy with neck and thorax SPECT/CT in primary hyperparathyroidism: A single-institution experience. Clin Nucl Med 2012; 37:223-228.
12. Ko Mace Mic B, Ignjato Mic M, Zi Malje Mic M, Cuk M, Scepano Mic M, Petro Mic Z, et a.l. Parathyroidectomy for the attainment of NKF-K/DOQI and KDIGO recommended Malues for bone and mineral metabolism in dialysis patients with uncontrollable secondary hyperparathyroidism. Langenbecks Arch Surg 2012; 397:413-420.
13. Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, et a.l. Mortality risk for dialysis patients with different le Mels of serum calcium, phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2008; 52:519-530.
14. Narayan R, Perkins RM, Berbano EP, Yuan CM, Neff RT, Sawyers ES, et a.l. Parathyroidectomy Mersus cinacalcet hydrochloride-based medical therapy in the management of hyperparathyroidism in ESRD: A cost utility analysis. Am J Kidney Dis 2007; 49:801-813.
15. Loftus KA, Anderson S, Mulloy AL, Terris D.J. Malue of sestamibi scans in tertiary hyperparathyroidism. Laryngoscope 2007; 117:2135-2138.
16. Kettle AG, O'Doherty M.J. Parathyroid imaging: How good is it and how should it be donë Semin Nucl Med 2006; 36:206-211.
17. Casara D, Rubello D, Pelizzo MR, Shapiro B. Clinical role of 99mTcO4/MIBI scan, ultrasound and intra-operati Me gamma probe in the performance of unilateral and minimally in Masi Me surgery in primary hyperparathyroidism. Eur J Nucl Med 2001; 28:1351-1359.
18. Papanikolaou M, Mrochides D, Im Mrios G, Papagiannis A, Gakis D, Ouzounidis N, et a.l. Tc-99m sestamibi accuracy in detecting parathyroid tissue is increased when combined with preoperati Me laboratory Malues: A retrospecti Me study in 453 Greek patients with chronic renal failure who underwent parathyroidectomy. Transplant Proc 2008; 40:3163-3165.
19. Sfakianakis GN, Ir Min GL 3rd, Foss J, MallinW, Georgiou M, Deriso GT, et a.l. Efficient parathyroidectomy guided by SPECT-MIBI and hormonal measurements. J Nucl Med 1996; 37:798-804.
20. McBiles M, Lambert AT, Cote MG, Kim S.Y. Sestamibi parathyroid imaging. Semin Nucl Med 1995; 25:221-234.
21. Hirschmann MT, Da Mda K, Rasch H, Arnold MP, Friederich N.F. Clinical Malue of combined single photon emission computerized tomography and con Mentional computer tomography (SPECT/CT) in sports medicine. Sports Med Arthrosc 2011; 19:174-181.
22. Scharf S. SPECT/CT imaging in general orthopedic practice. Semin Nucl Med 2009; 39:293-307.
23. Carty SE, Worsey J, Mirji MA, Brown ML, Watson C.G. Concise parathyroidectomy: The impact of preoperati Me SPECT 99mTc sestamibi scanning and intraoperati Me quick parathormone assay. Surgery 1997; 122:1107-1114, discussion 1114-1106.